Institut Curie

Jackson, R. et al.
Functional variants of human papillomavirus type 16 demonstrate host genome integration and transcriptional alterations corresponding to their unique cancer epidemiology
BMC Genomics. (2016) Nov 2.17(1):851. Erratum in: BMC Genomics. 2016 Dec 12.17 (1):1018
doi:

Chauvin C. et al.
High-throughput drug screening identifies Pazopanib and Clofilium Tosylate as promising treatments for Malignant Rhabdoid Tumors.
Cell Rep. (2017) Nov. 21(7):1737-1745.
doi: 10.1016/j.celrep.2017.10.076

Plouhinec JL. et al.
A molecular atlas of the developing ectoderm defines neural, neural crest, placode, and nonneural progenitor identity in vertebrates.
PLoS Biol. (2017) Oct. 15(10):e2004045.
doi: 10.1371/journal.pbio.2004045

Goudot C. et al.
Aryl Hydrocarbon receptor controls monocyte differentiation into dendritic cells versus macrophages.
Immunity (2017) Sep. 47(3):582-596.e6.
doi: 10.1016/j.immuni.2017.08.016

Cabel L. et al.
Circulating tumor DNA changes for early monitoring of anti-PD1 immunotherapy: a proof-of-conceptstudy.
Ann Oncol. (2017) Aug. 28(8):1996-2001.
doi: 10.1093/annonc/mdx212

Pincez T. et al.
Feasibility and clinical integration of molecular profiling for target identification in pediatric solid tumors.
Pediatr Blood Cancer (2017) Jun. 64(6).
doi: 10.1002/pbc.26365

Le Tourneau C. et al.
The SHIVA01 trial: what have we learned?
Pharmacogenomics (2017) Jun. 18(9):831-834.
doi: 10.2217/pgs-2017-0062

Richer W. et al.
Embryonic signature distinguishes pediatric and adult rhabdoid tumors from other SMARCB1-deficient cancers.
Oncotarget (2017) May. 8(21):34245-34257.
doi: 10.18632/oncotarget.15939

Euceda LR. et al.
Metabolic response to Everolimus in patient-derived triple-negative breast cancer xenografts.
J Proteome Res. (2017) May. 16(5):1868-1879.
doi: 10.1021/acs.jproteome.6b00918